`
`Case 1:14—cv-01117—GMS Document 4 Filed 09/02/14 Page 1 of 1 PagelD #: 144
`A0 I20 Rev. 08/10
`
` 'I‘O'
`
`'
`
`Mail Stop 8
`Director of the us. Patent and Trademark Office
`P.0. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the US. District Court
`District of Delaware
`on the following
`
`CI Trademarks or
`
`[3 Patents.
`
`( [I the patent action involves 35 U.S.C. §292.);
`
`DOCKET NO.
`
`PLAINTIFF
`
`DATE FILED
`9/2/2014
`
`U.S. DISTRICT COURT
`
`DEFENDANT
`
`District of Delaware
`
`CEPHALON, INC.
`
`NANG KUANG PHARMACEUTICAL CO., LTD. and
`CANDA NK-1, LLC
`
`HOLDER OF PATENT 0R TRADEMARK
`
`m %f¥&$2fif§i
`
`DATE INCLUDED
`
`INCLUDED BY
`
`[J Amendment
`
`C] Answer
`
`I] Cross Bill
`
`[:1 Other Pleadin
`
`In the above—entitled case, the following decision has been rendered orjudgement issued:
`DECISION/JUDGEMENT
`
`Dramas/Q whom/i) / 4.)!!— WN")
`
`CLERK ‘
`
`United States Dstrict Court
`.
`844 N. King Street. Unit 18
`II.
`II
`
`Copy l-Upon initiation of action, mail this copy to Direc r Copy 3—Upon termination ofaetion. mail this copy to Director
`Copy Z—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`
`
`